Companies: 10,304     total market cap: €109.516 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰$SGD🇸🇬
Alnylam Pharmaceuticals
ALNY
#626
Rank
€30.28 B
Marketcap
🇺🇸 United States
Country
234,79 €
Share price
1.06%
Change (1 day)
37.36%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Revenue for Alnylam Pharmaceuticals (ALNY)

Revenue in 2024 (TTM): €1.91 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is €1.99 Billion. In 2023 the company made a revenue of €1.65 Billion an increase over the revenue in the year 2022 that were of €0.96 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alnylam Pharmaceuticals from 2004 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) €1.91 B16.06%
2023 €1.65 B71.01%
2022 €0.96 B29.73%
2021 €0.74 B86.05%
2020 €0.40 B104.27%
2019 €0.19 B199.58%
2018 €65.47 M-12.62%
2017 €74.93 M67.14%
2016 €44.83 M19.28%
2015 €37.58 M-9.59%
2014 €41.57 M21.72%
2013 €34.15 M-32.29%
2012 €50.44 M-20.84%
2011 €63.72 M-15.27%
2010 €75.21 M7.19%
2009 €70.17 M2.01%
2008 €68.78 M97.33%
2007 €34.85 M70.8%
2006 €20.4 M322.97%
2005 €4.82 M53%
2004 €3.15 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Arrowhead Pharmaceuticals
ARWR
€3.38 M-99.83%🇺🇸 USA
Regeneron Pharmaceuticals
REGN
€13.18 B 561.02%🇺🇸 USA
Sarepta Therapeutics
SRPT
€1.56 B-21.69%🇺🇸 USA
OPKO Health
OPK
€0.67 B-66.04%🇺🇸 USA
Regulus Therapeutics
RGLS
N/AN/A🇺🇸 USA
Novartis
NVS
€47.55 B 2,284.00%🇨🇭 Switzerland
Sanofi
SNY
€50.94 B 2,454.29%🇫🇷 France
Teva Pharmaceutical Industries
TEVA
€15.96 B 700.60%🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com